UNSPSC 51171710: Alosetron

This classification denotes a 5-ht3 receptor antagonist with the molecular formula C17H18N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 13Z9HTH115, chemically known as 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1h-imidazol-4-yl)methyl)-1h-pyrido(4,3-b)indol-1-one but generally known as alosetron, which bears US NIH Compound Identifier 2099. Alosetron comes in base and hydrochloride forms. European Medicines Agency schedules Alosetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05358MIG.

UNSPSC 51171710 Alosetron, a Commodity code, appears in state and local procurement activity focused on drug testing and specimen collection services rather than the pharmaceutical product nominally named by the code. Collin County Community Supervision and Corrections Department recently posted RFP 2026-327 for offender specimen collection and drug testing services, a solicitation that encompasses staffing collection sites, operating randomized testing notification systems, performing immunoassay screening with LC/MS/MS or GC/MS confirmation, and conducting alternative testing methodologies including oral fluid and hair analysis. The work involves end-to-end laboratory and collection infrastructure, not pharmaceutical procurement. State and local issuers using this code appear limited to corrections and community supervision departments managing offender monitoring programs. The mismatch between the code's nominal scope (a specific pharmaceutical product) and the actual work being solicited (laboratory testing operations) suggests the code may be miscategorized in the state and local procurement system or applied inconsistently across jurisdictions.

Collin County, Texas, represents the only recent solicitation activity visible under this code. RFP 2026-327 carries an estimated contract value of $600,000 over an initial two-year term with three optional one-year renewal periods. Proposals were due July 23, 2026, with an anticipated award date of August 10, 2026. The scope encompasses approximately 25,031 annual tests across five-panel and six-panel screens with ancillary testing, pricing on a per-test basis across three service models (screening only, confirmation after screening, and screening with automatic confirmation of positives). Lab certification from SAMHSA, Texas DPS, or CAP is required. The lack of additional recent opportunities in the dataset suggests minimal recent state and local procurement activity under this code beyond the Collin County solicitation.